Polysubstance Use Facts
A factsheet about the dangers of polysubstance use.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
A factsheet about the dangers of polysubstance use.
The Project RESPECT team supports patients throughout their recovery journey during the entire first year postpartum and offer monitored, acute substance withdrawal treatment and induction of medications for opioid use disorder in pregnant patients seeking treatment.
This web page provides updated resources, including guides and tools from SAMHSA, for practitioners related to screening, brief intervention, and referral to treatment (SBIRT).
Provides a sample treatment agreement for buprenorphine/naloxone.
Provides a sample treatment agreement for buprenorphine/Naloxone.
Provides a sample consent for treatment with buprenorphine/naloxone.